Learning Curves Don't Come With a Package Insert

Radiopharmaceuticals are not new to oncology, but they're new to most of the pharmacists reading this. That gap—between a therapy existing and a field actually absorbing it—is worth sitting with for a minute, because it is rarely instant and rarely comfortable.

Putting together this issue's cover feature meant starting mostly from scratch. Half-life isn't just a number on a label when the drug itself is radioactive; it dictates who can be in the room, how waste is handled, and how a dose is timed to a patient’s schedule rather than the other way around. None of that is intuitive if your training did not build it in from the start. It has to be learned deliberately, the way anything genuinely new to a field gets learned: slowly, with some discomfort, and usually by people willing to admit what they do not yet know.

There's also a cost conversation buried inside the science that most people are not used to having yet, one that touches infrastructure, reimbursement, and access all at once and doesn't resolve just because the clinical data look good. That is part of what makes this moment different from a typical new drug rollout. It is not just a prescribing decision. It is closer to standing up a small, new operational discipline within departments that were never built with radioactivity in mind, and doing so while the science is still moving.

That is not a knock on the field—it’s actually the opposite. Oncology pharmacy has absorbed enormous complexity over the past decade: cell and gene therapies, bispecifics, and antibody-drug conjugates, each one arriving with its own new grammar that eventually became second nature. Radiopharmaceuticals are just the current version of that pattern—a technology that looks foreign until it doesn’t. The learning curve is real, and so is the fact that it's climbable, and pharmacists have climbed steeper ones before without much fanfare.

There is something worth admiring in a field that keeps choosing to do this to itself, over and over, rather than settling into what it already knows well. It would be easier not to. Reading through this issue, that willingness to stay uncomfortable in the direction of getting better shows up more than once, and it is the reason this profession keeps ending up in rooms it was not originally built for.